Gastric carcinoma treated by chemotherapy after resection: a controlled study

Area of Science:

• Oncology
• Surgical Oncology
• Medical Oncology

Background:

• Gastric carcinoma remains a significant global health challenge.
• Adjuvant chemotherapy is a common treatment modality after radical resection for gastric cancer.
• Optimizing adjuvant therapy to improve patient survival is an ongoing research area.

Purpose of the Study:

• To evaluate the efficacy of a combined chemotherapy regimen (5-fluorouracil, vinblastine, cyclophosphamide) as adjuvant therapy in patients who underwent radical resection for gastric carcinoma.
• To compare the survival rates of patients receiving adjuvant chemotherapy with those receiving standard care (control group).

Main Methods:

• A prospective controlled study was conducted with 53 patients diagnosed with gastric carcinoma.
• Patients were randomly assigned to either a control group (26 patients) or a chemotherapy group (27 patients).
• The chemotherapy group received a combination of 5-fluorouracil, vinblastine, and cyclophosphamide post-surgery.

Main Results:

• The study included 53 patients with gastric carcinoma who underwent radical resection.
• Patient groups were comparable in age, sex, tumor location, resection type, and pathology.
• No statistically significant difference in survival rates was observed between the adjuvant chemotherapy group and the control group.

Conclusions:

• The combined chemotherapy regimen of 5-fluorouracil, vinblastine, and cyclophosphamide did not demonstrate a significant survival benefit in patients with gastric carcinoma following radical resection.
• Further research may be needed to explore alternative or modified chemotherapy regimens for improving outcomes in resected gastric cancer.